Daniel Polsky, PhD, MPP
Bloomberg Distinguished Professor of Health Policy and Economics, Johns Hopkins University Carey School of Business and Department of Health Policy and Management, Bloomberg School of Public Health
In March 2019, Dr. Daniel Polsky joined Johns Hopkins as the Bloomberg Distinguished Professor of Health Policy and Management at the Johns Hopkins University Bloomberg School Public Health and the Carey School of Business. He spent the past 22 years at the University of Pennsylvania as Robert D. Eilers Professor of Health Care Management and Professor of Medicine in the Wharton School and the Perelman School of Medicine. The past seven years he was Executive Director of the Leonard Davis Institute of Health Economics where he led 300 senior fellows and their $110 million in research grants addressing the health care system challenges of quality of care, care delivery transformation towards value, care access, and equity. Dr. Polsky is a member of the National Academy of Medicine and currently serves on the National Academy of Medicine’s Board of Population Health and the Health and Medicine Committee that oversees the NAM Boards. He serves on the Congressional Budget Office’s Panel of Health Advisers and was the senior economist on health issues at the President’s Council of Economic Advisers.
Dr. Polsky’s research has advanced our understanding of the cost and quality tradeoff of interventions whether they are changes to large federal programs or local programs. He has become a leading figure in the economic evaluation of novel medical interventions, particularly when done prospectively within clinical trials. He is a co-author of the book “Economic Evaluation in Clinical Trials” recently published by Oxford University Press. Dr. Polsky has been the PI of two R01s that worked to develop the methods of cost-effectiveness analysis. He is the co-director of the Policy Core for The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH). The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy and HCV and HIV care of substance users. The Policy Core supports CHERISH researchers in employing state-of-the-art dissemination practices to increase visibility and impact of research among policymakers and the public.